|
CAR-boosting vaccines for neuroblastoma |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
Regulation of medulloblastoma metastasis by the FOS transcription factor |
Columbia University Medical Center |
Northwestern Mutual Foundation |
|
Testing a novel acylfulvene in malignant rhabdoid tumor |
The Johns Hopkins University School of Medicine |
Northwestern Mutual Foundation |
|
Lipid nanoparticle delivery of CRISPR/Cas9 reagents for disruption of oncogenic translocations in alveolar rhabdomyosarcoma |
University of California, Los Angeles |
Northwestern Mutual Foundation |
|
CNS status and MRD at end of induction stratified by race and ethnicity |
Emory University |
Northwestern Mutual Foundation |
|
Treatment of drug-resistant medulloblastoma with RNA translation inhibitors |
University of Michigan |
Northwestern Mutual Foundation |
|
Deciphering the tumor microenvironment in metastatic osteosarcoma for therapeutic benefit |
Dana-Farber Cancer Institute |
Northwestern Mutual Foundation |
|
Maximization of oncolytic virotherapy for pediatric brain tumor through inhibition of IDO and BTK |
Augusta University |
Northwestern Mutual Foundation |
|
IL7 signaling enhanced CAR T cells to treat pediatric solid tumors |
Baylor College of Medicine |
Northwestern Mutual Foundation |
|
Incidence and grades of adverse events during treatment for pediatric acute lymphoblastic leukemia |
Emory University |
Northwestern Mutual Foundation |